drugset / Trial / NCT05621447
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]TAS-303 following oral single dose
Timeline
- Start
- 2022-09-07
- Primary completion
- 2022-11-03
- Completion
- 2023-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PARENT OF TAS-303 | Small molecule | — | Oral |
Indications
No indication recorded.